Aidian Dineen
Director, HEOR
专长:
Aidan’s broad experience includes both pharmaceutical and medical device products. Specifically, he has developed value communications, peer-reviewed manuscripts, pharmacoeconomic models, cost-calculators, conference abstracts and posters, and conducted literature reviews. Aidan’s experience spans multiple disease areas including cardiac arrhythmias, oncology, migraine, asthma, total knee arthroplasty, Alzheimer’s, neuromuscular disorders, and rare diseases. He has experience in global HEOR programs and regional HTA submissions, having contributed to over a dozen Canadian public and private reimbursement submissions.
He holds a PhD in Molecular and Medical Genetics from the University of Calgary, an MSc in Biology from McMaster University, and an Honours BSc in Developmental Biology from the University of Toronto.
Articles by Aidian Dineen
Unlocking Insights: EVERSANA’s Value & Evidence Team’s Impact on Economic and Healthcare Resource Utilization Outcomes in Robotic vs. Manual Total Knee Arthroplasty
The use of robotics in surgical procedures is becoming increasingly popular, with the potential to reshape the landscape of modern surgery. In total knee arthroplasty (TKA), the increased adoption of robotics has improved clinical outcomes, including increased precision and standardization compared to the manual procedure. While these findings have been well documented, evidence of the […]